AI Science Tracker
EN

Predicting postoperative rehemorrhage in hypertensive intracerebral hemorrhage using noncontrast CT radiomics and clinical data with an interpretable machine learning approach

Department of Neurosurgery, Lu'an Hospital of Traditional Chinese Medicine, No. 76 Renmin Road, Jin'an District, Lu'an, 237000, Anhui, China · 27 Apr 2024 · medicine

Discovery

Predicting postoperative rehemorrhage in hypertensive intracerebral hemorrhage using noncontrast CT radiomics and clinical data with an interpretable machine learning approach

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: An SVM radiomics model predicted postoperative rehemorrhage in 609 patients and was checked in an external verification cohort; this was retrospective prediction, not evidence of clinical benefit.

Technology: SVM radiomics model for postoperative rehemorrhage

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
SVM radiomics model for postoperative rehemorrhage
Limitation / still unknown
The external verification remained retrospective; prospective use and improved patient outcomes were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/38678066 · https://doi.org/10.1038/s41598-024-60463-2 · https://pubmed.ncbi.nlm.nih.gov/38678066/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.